依达赛珠单抗（Praxbind）用于在急诊修复包含性破裂横弓动脉瘤之前逆转达比加群的作用。
Idarucizumab (Praxbind) for reversal of pradaxa prior to emergent repair of contained ruptured transverse arch aneurysm.
作者信息
Belli Erol Vahit, Lee Teng
机构信息
Department of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, FL 32611; Department of Cardiovascular Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Department of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, FL 32611, USA.
出版信息
Ann Card Anaesth. 2017 Jul-Sep;20(3):369-371. doi: 10.4103/0971-9784.210426.
Idarucizumab before cardiopulmonary bypass was used for the reversal of dabigatran during an emergent frozen elephant trunk repair of a transverse arch aneurysm. Reversal was successful and minimal not massive transfusion was required with no abnormal sequelae seen with use before cardiopulmonary bypass.
在进行横弓动脉瘤的紧急冰冻象鼻修复术时，在体外循环前使用艾达司珠单抗来逆转达比加群的作用。逆转成功，仅需少量而非大量输血，且在体外循环前使用未观察到异常后遗症。
Zotero 插件